Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Urge to cough is significantly abolished by nasal thymol application

Silvia Gavliakova, Zuzana Biringerova, Eva Hanuskova, Tomas Buday, Ivan Poliacek, Jana Plevkova
European Respiratory Journal 2013 42: P1594; DOI:
Silvia Gavliakova
1Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zuzana Biringerova
1Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Hanuskova
1Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Buday
1Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Poliacek
2Department of Medical Biophysics, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Plevkova
1Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia (Slovak Republic)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Thymol is empirically used to relieve symptoms of respiratory diseases. It is a component of thyme herb extract, a terpene with antibacterial, antifungal, and antioxidative activity. In the respiratory system it is known to modulate mucociliary transport, airway β2 receptors, and combined with ivy extract attenuates coughing in children with acute bronchitis. Thymol also acts on the transient receptor potential cation channel, subfamily V, member 3 (TRPV3) channels which are expressed in the skin, tongue, and afferent somatosensory neurons. In the present study we the tested hypothesis that intranasal administration of thymol would modulate the cough reflex possibly by trigeminal/olfactory pathways. Eighteen healthy volunteers with normal lung function were tested for cough. Before and after nasal administration of thymol (0.025 ml, 10-3M) into both nostrils, urge-to-cough, cough threshold, cumulative and total count of coughs per provocation were estimated during standardized and validated capsaicin cough challenge. Nasal thymol challenges induced pleasant olfactory sensations and in 6 out of the 18 subjects also a transient (up to 2 min) mild cooling sensation. Cough threshold was not influenced when compared with intranasal saline and vehicle challenges (12.5 vs. 13.2 vs. 10.2μM of capsaicin to induce two or more coughs (C2), respectively, but the total count of coughs after nasal thymol challenge was significantly lower than that obtained after saline or vehicle (19 vs. 20 vs. 14 coughs/provocation, respectively; p<0.05). Importantly, subjects did not report the urge to cough, which appeared to correspond to C2. We conclude that the modulation of cough by thymol is, to a great extent, of olfactory origin.

  • Cough
  • Physiology
  • Treatments
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Urge to cough is significantly abolished by nasal thymol application
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urge to cough is significantly abolished by nasal thymol application
Silvia Gavliakova, Zuzana Biringerova, Eva Hanuskova, Tomas Buday, Ivan Poliacek, Jana Plevkova
European Respiratory Journal Sep 2013, 42 (Suppl 57) P1594;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Urge to cough is significantly abolished by nasal thymol application
Silvia Gavliakova, Zuzana Biringerova, Eva Hanuskova, Tomas Buday, Ivan Poliacek, Jana Plevkova
European Respiratory Journal Sep 2013, 42 (Suppl 57) P1594;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Omalizumab, airway obstruction and remodeling
  • Central role for the TRPV4-ATP-P2X3 axis in sensory nerve activation and the late asthmatic response
  • Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society